EUVIMEDEUVIMED entdecken
Crossref

Fosamax Fractures—Justice Has Not Been Served

Gregory Curfman

JAMA · 2024

DOI: 10.1001/jama.2024.6077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, 2024. Verfasst von Gregory Curfman. Beteiligte Einrichtung: Executive Editor, JAMA , Chicago, Illinois. Hauptthemen laut MEDLINE: Fractures, Bone, Alendronate, Bone Density Conservation Agents, Hip Fractures. Die Arbeit nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Viewpoint discusses the ongoing lawsuit between plaintiffs who had been affected by atypical femoral fractures while receiving alendronate and the drug manufacturer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fractures, BoneAlendronateBone Density Conservation AgentsHip FracturesDrug LabelingHumansUnited StatesUnited States Food and Drug AdministrationBone RemodelingFractures, SpontaneousDrug Approval

Substanzen

AlendronateBone Density Conservation Agents

Autor:innen und Institutionen

  • Executive Editor, JAMA , Chicago, Illinois.

Zitieren

APA

Curfman, G. (2024). Fosamax Fractures—Justice Has Not Been Served. JAMA. https://doi.org/10.1001/jama.2024.6077

Vancouver

Curfman G. Fosamax Fractures—Justice Has Not Been Served. JAMA. 2024. doi:10.1001/jama.2024.6077

BibTeX
@article{Curfman2024,
  author = {Curfman, Gregory},
  title = {Fosamax Fractures—Justice Has Not Been Served},
  journal = {JAMA},
  year = {2024},
  doi = {10.1001/jama.2024.6077}
}
Kostenlos starten →